Samaritan looks to forge European partnerships, expand operations

Looking to develop new clinical trial partnerships, Samaritan Pharmaceuticals has hired a chief for its European operations and opened an office in Athens. Dr. Christos Dakas will take over as managing director of European operations, which includes Samaritan Ireland. Samaritan is working in collaboration with Georgetown University in advancing eight compounds.

Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals, stated, "In the foreseeable future, we ambitiously see Samaritan as being a global company. So, it is with absolute joy that we welcome Dr. Dakas to the Samaritan team. We see him as having the passion, drive and spirit to make it happen in Europe and the developing countries."

- read this press release for more

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.